Publicaties
Effect of the male factor on the clinical outcome of intracytoplasmic sperm injection combined with preimplantation aneuploidy testing Vrije Universiteit Brussel
OBJECTIVE: To evaluate the impact of the male factor on the outcomes of intracytoplasmic sperm injection (ICSI) cycles combined with preimplantation genetic testing for aneuploidies (PGT-A).
DESIGN: Observational longitudinal cohort study.
SETTING: Private in vitro fertilization (IVF) center.
PATIENT(S): A total of 1,219 oocyte retrievals divided into five study groups according to sperm parameters: normozoospermia ...
The experience of 3 years of external quality assessment of preimplantation genetic diagnosis for cystic fibrosis. Vrije Universiteit Brussel
Preimplantation genetic diagnosis (PGD) for Huntington's disease: the experience of three European centres. Vrije Universiteit Brussel
Hereditary breast and ovarian cancer and reproduction: an observational study on the suitability of preimplantation genetic diagnosis for both asymptomatic carriers and breast cancer survivors Vrije Universiteit Brussel
Provision and quality assurance of preimplantation genetic diagnosis in Europe Vrije Universiteit Brussel
Preimplantation genetic diagnosis for mitochondrial DNA disorders : ethical guidance for clinical practice Universiteit Gent
Gonadotropin releasing hormone agonists or antagonists for preimplantation genetic diagnosis (PGD)? Vrije Universiteit Brussel
Background: The use of GnRH analogue medication is essential in reproductive medicine to avoid premature ovulation by pituitary suppression for the duration of ovarian stimulation by gonadotrophins. The type of pituitary suppression by either GnRH agonist analogues versus GnRH antagonist analogues may result in different embryological hence clinical results. Preimplantation genetic diagnosis is a subtype of IVF in which embryos are created ...